• Maharashtra FDA cancels licenses of 27 & suspends licenses of 94 units for non-compliance to D&C Act

• Indian pharma pivots toward specialty therapeutics and AI-powered drug discovery to reduce timelines & costs

• Ayush export declines by 7.4% in first nine months of FY 26

• NPPA asks cos to revise prices of 17 drugs following BCD exemption